Hyaluronan (HA) is a ubiquitous component of the extracellular matrix
(ECM) and occurs transiently in both the cell nucleus and cytoplasm. I
t has been shown to promote cell motility, adhesion, and proliferation
and thus it has an important role in such processes as morphogenesis,
wound repair, inflammation, and metastasis. These processes require m
assive cell movement and tissue reorganization and are always accompan
ied by elevated levels of HA. Many of the effects of HA are mediated t
hrough cell surface receptors, three of which have been molecularly ch
aracterized, namely CD44, RHAMM, and ICAM-1. Binding of the HA ligand
to its receptors triggers signal transduction events which, in concert
with other ECM and cytoskeletal components, can direct cell trafficki
ng during physiological and pathological events. The HA mediated signa
ls are transmitted, at least in part, by the activation of protein pho
sphorylation cascades, cytokine release, and the stimulation of cell c
ycle proteins. A variety of extracellular signals regulate the express
ion of both HA and the receptors necessitating that HA-receptor signal
ling is a tightly controlled process. Regulated production of soluble
forms of the receptors, alternately spliced cell surface isoforms, and
glycosylation variants of these receptors can dramatically modulate H
A binding, ligand specificity, and stimulation of the signalling pathw
ay. When these processes are deregulated cell behaviour becomes uncont
rolled leading to developmental abnormalities, abnormal physiological
responses, and tumorigenesis. The elucidation of the molecular mechani
sms regulating HA-mediated events will not only contribute greatly to
our understanding of a variety of disease processes but will also offe
r many new avenues of therapeutic intervention. (C) 1996 Wiley-Liss, I
nc.